Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

44.70
Delayed Data
As of 4:01pm ET
 0.00 / 0.00%
Today’s Change
36.76
Today|||52-Week Range
45.84
+16.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line316.0M615.0M-329.0M798.0M
 
 
 
 
 
Depreciation347.0M347.0M340.0M319.0M
 
 
 
 
 
Total Other Cash Flow629.0M62.0M1.0B297.0M
 
 
 
 
 
Funds From Operations1.3B1.0B1.0B1.4B
 
 
 
 
 
Extraordinary Items-25.0M0.000.000.00
 
 
Funds From/For Other Operating Expenses1.4B115.0M-206.0M244.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-93.0M909.0M1.2B1.2B
 
 
 
 
 
 
InvestingIncrease In Investments-----182.0M-1.8B
 
 
 
Decrease In Investments446.0M-446.0M0.003.7B
 
 
 
 
Capital Expenditures-243.0M-247.0M-312.0M-319.0M
 
 
 
 
 
Fixed Asset Disposal25.0M0.000.000.00
 
 
Net Assets From Acquisitions -----66.0M-7.0M
 
 
 
Other Investing - Uses-2.0M------
 
 
Other Investing - Sources----6.0M8.0M
 
 
 
Net Cash Flow Investing226.0M-1.5B-554.0M1.6B
 
 
 
 
 
 
FinancingShort Term Borrowings-583.0M298.0M-397.0M-1.1B
 
 
 
 
 
Long Term Borrowings0.00-132.0M-38.0M15.1B
 
 
 
 
Long Term Debt Reduction-7.0M-3.0M-1.0M-1.0M
 
 
 
 
 
Net Proceeds Stock Sale87.0M43.0M76.0M42.0M
 
 
 
 
 
Common Preferred Redeemed-519.0M-1.0M-2.0M0.00
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-385.0M-384.0M-384.0M-386.0M
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing25.0M0.000.00170.0M
 
 
 
Net Cash Flow - Financing-1.4B-179.0M-746.0M13.5B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-368.0M-16.0M5.0M-104.0M
 
 
 
 
 
 
Net Change In Cash-1.3B-740.0M-83.0M16.2B